Publications
Fabrellas N, Carol M, Palacio E, Aban M, Lanzillotti T, Nicolao G, Chiappe MT, Esnault V, Graf‐Dirmeier S, Helder J, Gossard A, Lopez M, Cervera M, Dols LL, The LiverHope consortium investigators
 |
Nursing care of patients with cirrhosis |
Hepatology. Jan 16. doi: 10.1002/hep.31117
Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S, Roux O, Uschner FE, de Wit K, Zaccherini G, Alessandria C, Angeli P, Bernardi M, Beuers U, Caraceni P, Durand F, Mookerjee RP, Trebicka J, Vargas V, Andrade RJ, Carol M, Pich J, Ferrero J, Domenech G, Llopis M, Torres F, Kamath PS, Abraldes JG, Solà E, Ginès P.
 |
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. |
Lancet Gastroenterol Hepatol. 2019 Oct 10. doi: 10.1016/S2468-1253(19)30320-6
Solé C, Solà E, Huelin P, Carol M, Moreira R, Cereijo U, Mas JM, Graupera I, Pose E, Napoleone L, dePrada G, Juanola A, Fabrellas N, Torres F, Morales‐Ruiz M, Farrés J, Jiménez W, Ginès P.
|
Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival |
Liver Int. 2018 Dec 29. doi: 10.1111/liv.14037
Pose E, Trebicka J, Mookerjee RP, Angeli P, Ginès P.
|
Statins: Old drugs as new therapy for liver diseases? |
J Hepatol. 2018 Aug.
Solé C, Pose E, Solà E, Ginès P.
|
Hepatorenal syndrome in the era of acute kidney injury. |
Liver Int. 2018;00:1-11.
Ginès P, Shiv, S.
|
More Than Meets the Eye in Using Interleukin 6 as a Marker of Inflammation and Prognostic Factor for Patients With Cirrhosis. |
Clinical Gastroenterology and Hepatology. 2018;16:630-632.
Solà E, Ginès P.
|
Pro: Acute-on-chronic liver failure. |
Liver Transpl. 2017 Jul 8. doi: 10.1002/lt.24812.
Hernaez R, Solà E, Moreau R, Ginès P.
|
Acute-on-chronic liver failure: an update. |
Gut. 2017 Mar;66(3):541-553. doi: 10.1136/gutjnl-2016-312670. Epub 2017 Jan 4.